Decision aid
BehavioralA web-based decision aid to assist surrogate decision makers in prolonged mechanical ventilation decisions
NCT Number: NCT01751061
Deciding about prolonged life support for critically ill patients can be very difficult. Therefore, the investigators are doing a study to see if an internet-based decision aid can improve the quality of decision making for substitute decision makers of patients who are in the intensive care unit (ICU).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University of North Carolina, Chapel Hill, North Carolina, United States
The process of making a decision about whether or not to provide prolonged life support is seriously deficient among clinicians and the surrogate decision makers for critically ill patients. To address this problem, we propose a randomized, controlled trial to determine if an innovative web-based decision aid compared to usual care control can improve the quality of decision making (defined as clinician-surrogate concordance for prognosis, quality of communication, and medical comprehension), reduce surrogates' psychological distress (depression, anxiety, and post-traumatic stress syndrome disorder (PTSD) symptoms), and reduce patients' health care costs over 6-month follow up. We will enroll 410 surrogate decision makers for 273 patients (expected average of 1.5 surrogates per patient). This study has the potential both to improve how clinicians and surrogates interact in intensive care units and to increase the likelihood that life support decisions are aligned with patients' values.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Patient characteristics required for surrogate inclusion)
Exclusion criteria
(Patient characteristics that will exclude surrogates from study enrollment):
Inclusion criteria
for surrogate decision makers:
Exclusion criteria
for surrogate decision makers:
Physician and nurse inclusion criteria:
A web-based decision aid to assist surrogate decision makers in prolonged mechanical ventilation decisions
usual ICU care
Time frame: ~2-7 days post-randomization
Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the surrogate(s) and the clinician (ICU physician), and, therefore, can range from 0 to 100.
We report pre-intervention to post-intervention difference in the CSCS.
The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of either the treating ICU physician (primary outcome) or the nurse (secondary outcome) to the question, "What percent chance do you think [the patient/your loved one] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.
Time frame: Pre-randomization (study day 1) and 180 days post-randomization
We report here the difference between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary surrogate decision makers (not secondary).
HADS scores can range from 0 to 42 points; higher scores=more distress.
Time frame: Pre-randomization (study day 1) and 180 days post-randomization
Here we report PTSS score differences between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary (not secondary) surrogate decision makers.
PTSS scores can range from 10-70, with greater scores=more distress.
Time frame: Study day 1 and 180 days post-randomization
Here we report change in patient-centeredness score between Study day 1 (Interview 1) and 180 days post-randomization (Interview 4) for primary (not secondary) surrogate decision makers.
Scores can range from 12-48 points, with higher scores=greater patient-centeredness.
Time frame: Study day 1 (pre-randomization), ~2-7
Here we report MCS score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.
Scores can range from 0-8, with greater scores=better comprehension.
Time frame: Study day 1 (pre-randomization), ~2-7
Here we report QOC score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.
Scores range from 0-110, with higher scores=better quality of communication.
Time frame: ~2-7 days post-randomization
Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the primary surrogate decision maker and the IUC nurse, and, therefore, can range from 0 to 100.
We report pre-intervention to post-intervention difference in the CSCS.
The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of the nurse to the question, "What percent chance do you think [the patient/your loved one] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03159208
Chronic Critical Illness, Critical Illness
Denver, Colorado, United States
View Trial DetailsNCT01230099
Chronic Critical Illness, Critical Illness
New York, United States
View Trial DetailsNCT07372794
Critical Illness, Disease Attributes
Beijing, Beijing Municipality, China
View Trial DetailsNCT07177183
Critical Illness, Disease Attributes
Brno, Czechia
View Trial Details